Delivery Order SPE2DR25D1201-SPE2DR26FAJPB
Award Date 10/24/25
Potential Completion Date 11/17/25
Potential Value $12K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $23,660 delivery order to AmerisourceBergen Drug Corp for SKYRIZI 360 mg/2.4 ml on-body applicators on September 3, 2025, with completion scheduled for September 24, 2025. SKYRIZI is a prescription biologic medication used to treat moderate to severe plaque psoriasis and other inflammatory conditions. The contract represents a firm fixed-price delivery order with no set-aside designation, indicating competitive award through open procurement channels....
- The Defense Logistics Agency awarded a $11,830 firm fixed-price delivery order to AmerisourceBergen Drug Corp for SKYRIZI 360 mg/2.4 ml on-body applicators on August 26, 2025, with completion targeted for September 17, 2025. SKYRIZI is a biologic medication indicated for the treatment of plaque psoriasis and other inflammatory dermatological conditions. The award represents a competitively awarded, non-set-aside transaction executed through AmerisourceBergen's existing indefinite delivery...
- The Defense Logistics Agency awarded a delivery order valued at $11,830.00 to AmerisourceBergen Drug Corp for SKYRIZI 360 mg/2.4 ml on-body applicators on September 9, 2025. This firm fixed-price, non-set-aside contract is scheduled for completion by September 30, 2025, and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. SKYRIZI is a biologic medication used to treat psoriasis and other inflammatory conditions, and this delivery order represents a specific...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of SKYRIZI 360 mg/2.4 mL on-body injection units, valued at $11.8K with a firm fixed price structure. This is a non-set-aside competitive award issued on August 13, 2025, with an ultimate completion date of September 4, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. SKYRIZI is a prescription biologic medication indicated for the treatment of...
- The Defense Logistics Agency awarded a delivery order valued at $11,830.00 to AmerisourceBergen Drug Corp for the supply of SKYRIZI 360 mg/2.4 ml on-body injectors. This firm fixed-price, competitively awarded contract was issued on July 29, 2025, with an ultimate completion date of August 19, 2025. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania. SKYRIZI is a biologic immunosuppressant medication used in the treatment of moderate-to-severe plaque psoriasis...
- The Defense Logistics Agency awarded a $25,209.26 delivery order to AmerisourceBergen Drug Corp for SKYRIZI 360 MG/2.4 ML on-body injectors on April 29, 2025, with a completion date of May 20, 2025. This firm fixed price, non-set-aside contract was issued under a competitive procurement process and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. SKYRIZI is a biologic treatment used for dermatological conditions, representing part of the company's...
- The Defense Logistics Agency awarded a delivery order valued at $11,830.00 to AmerisourceBergen Drug Corp for SKYRIZI 360 mg/2.4 ml on-body injectable medication. This firm fixed price delivery order, issued on July 16, 2025, with an ultimate completion date of August 6, 2025, represents a non-competitive award under an existing contract vehicle. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. SKYRIZI is a biologic immunosuppressant...
- The Defense Logistics Agency awarded a $20,767.87 firm fixed-price delivery order to AmerisourceBergen Drug Corp for SKYRIZI 150 mg/mL pens on September 4, 2025, with completion scheduled for September 5, 2025. SKYRIZI is a biologic medication used to treat inflammatory skin conditions such as plaque psoriasis and psoriatic arthritis. This is a non-set-aside competitive award, reflecting AmerisourceBergen's demonstrated capability to meet federal pharmaceutical procurement requirements. The...
- The Defense Logistics Agency awarded a $12,467 delivery order to AmerisourceBergen Drug Corp for SKYRIZI 360 mg/2.4 mL on-body injectors on October 24, 2025. This competitively awarded, firm fixed-price contract, which carries no set-aside designation, is scheduled for completion by November 17, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. SKYRIZI is a specialized biologic medication indicated for inflammatory skin conditions,...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $45,011.41 delivery order for SKYRIZI 150 mg/mL in pen/mL format, with an ultimate completion date of August 13, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a single delivery order execution under AmerisourceBergen's existing Indefinite Delivery Contract with DLA...